Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial
Authors | |
---|---|
Year of publication | 2021 |
Type | Article in Periodical |
Magazine / Source | Lancet Haematol |
MU Faculty or unit | |
Citation | |
Doi | http://dx.doi.org/10.1016/S2352-3026(20)30368-9 |